We are live on ! Find out more
COLL icon

Collegium Pharmaceutical

88 hedge funds and large institutions have $363M invested in Collegium Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

463% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 8

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

81.46% more ownership

Funds ownership: 0%81.46% (+81%)

24% more funds holding

Funds holding: 7188 (+17)

19% more capital invested

Capital invested by funds: $305M → $363M (+$58M)

69% less call options, than puts

Call options by funds: $238K | Put options by funds: $779K

Holders
88
Holders Change
+17
Holders Change %
+23.94%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
20
Increased
45
Reduced
8
Closed
3
Calls
$238K
Puts
$779K
Net Calls
-$541K
Net Calls Change
+$364K
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
1
Sectoral Asset Management
Quebec, Canada
$32.8M +$23.2M +1,398,911 +198%
EAM
2
Eventide Asset Management
Massachusetts
$32.4M +$1.12M +67,473 +3%
FM
3
Frazier Management
Washington
$29.4M
Franklin Resources
4
Franklin Resources
California
$28M +$14.8M +890,868 +98%
RSCM
5
Rock Springs Capital Management
Maryland
$24.9M +$914K +55,000 +4%
HM
6
HealthCor Management
New York
$22.2M +$437K +26,300 +2%
PHS
7
PFM Health Sciences
California
$22.1M +$16.9M +1,015,695 +252%
TGHSA
8
TPG Group Holdings (SBS) Advisors
Texas
$21.6M
BFA
9
BlackRock Fund Advisors
California
$14.5M +$3.94M +237,026 +34%
CCM
10
Cadian Capital Management
New York
$14.3M +$7.29M +438,860 +91%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$14.3M +$2.55M +153,600 +20%
Vanguard Group
12
Vanguard Group
Pennsylvania
$11.6M +$3.75M +225,553 +43%
HCMT
13
Highland Capital Management (Texas)
Texas
$10.7M +$5.96M +358,409 +110%
EAM
14
EverPoint Asset Management
Connecticut
$7.16M +$7.64M +460,000 New
CAM
15
Cormorant Asset Management
Massachusetts
$7.09M
Massachusetts Financial Services
16
Massachusetts Financial Services
Massachusetts
$6.99M -$995K -59,868 -12%
BIT
17
BlackRock Institutional Trust
California
$6.42M +$2.51M +151,044 +58%
Prudential Financial
18
Prudential Financial
New Jersey
$5.32M +$5.68M +341,860 New
BCMNY
19
Buckingham Capital Management (New York)
New York
$5.15M +$4.61M +277,578 +521%
PC
20
Pier Capital
Connecticut
$5.13M +$4.74M +284,929 +637%
State Street
21
State Street
Massachusetts
$4.53M +$1.52M +91,287 +46%
JGC
22
J. Goldman & Co
New York
$3.5M +$2.44M +146,850 +188%
Northern Trust
23
Northern Trust
Illinois
$3.35M +$647K +38,916 +22%
PA
24
Perceptive Advisors
New York
$3.06M +$3.27M +196,728 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$2.21M +$601K +36,133 +34%

COLL Hedge Fund Activity: Q4 2016 in Review

88 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2016, worth a combined $363M — up 19% from $305M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new COLL positions and 3 closed out — a net gain of 17 holders — while 45 added to existing stakes and 8 trimmed.

The largest buyer was Sectoral Asset Management, adding an estimated $23.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $995K.

  • 88 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2016, up from 71 in Q3 2016.
  • Funds reported $363M of Collegium Pharmaceutical stock for Q4 2016, up 19% quarter-over-quarter.
  • 20 funds opened new Collegium Pharmaceutical positions in Q4 2016 and 3 closed out, a net change of +17 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2016 was Sectoral Asset Management, an estimated $23.2M added.
  • The largest Collegium Pharmaceutical seller in Q4 2016 was Massachusetts Financial Services, an estimated $995K sold.

Based on aggregated 13F filings for Q4 2016.